<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0002835'>Aspiration</z:hpo> is a feared complication of anesthesia and is accompanied by increased morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Rapid sequence induction (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RSI</z:e>) describes the preferred procedure to perform endotracheal placement of the tubus in emergency cases of patients with an increased risk of <z:hpo ids='HP_0002835'>aspiration</z:hpo> of gastric contents </plain></SENT>
<SENT sid="2" pm="."><plain>For more than 50 years <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RSI</z:e> has consisted of the application of <z:chebi fb="0" ids="45652">suxamethonium</z:chebi> for <z:e sem="disease" ids="C0700323,C0234119" disease_type="Disease or Syndrome" abbrv="">neuromuscular blockade</z:e> because of its fast <z:hpo ids='HP_0003674'>onset</z:hpo> and ultra short duration </plain></SENT>
<SENT sid="3" pm="."><plain>Due to the serious side effects of <z:chebi fb="0" ids="45652">suxamethonium</z:chebi> attempts were made to find better alternative neuromuscular blocking drugs, e.g. <z:chebi fb="0" ids="8884">rocuronium</z:chebi>, to perform <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RSI</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIALS AND METHODS: In this small clinical series <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RSI</z:e> was performed for general anesthesia of ten pregnant women for Caesarean sections using 1.0 mg/kgBW <z:chebi fb="0" ids="8884">rocuronium</z:chebi> for induction and maintaining deep relaxation until the end of surgery </plain></SENT>
<SENT sid="5" pm="."><plain>For rapid reversal of the <z:e sem="disease" ids="C0700323,C0234119" disease_type="Disease or Syndrome" abbrv="">neuromuscular blockade</z:e> to a train-of-four (TOF) ratio of 0.9, the Âµ-cyclodextrin sugammadex was administered at the end of surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Major and minor side effects, such as cardiac dysrhythmia, anaphylactic reactions, <z:hpo ids='HP_0001609'>hoarseness</z:hpo> and postoperative <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> were documented </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The combination of <z:chebi fb="0" ids="8884">rocuronium</z:chebi> and sugammadex for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RSI</z:e> combines rapid <z:hpo ids='HP_0003674'>onset</z:hpo> and rapid reversal of <z:e sem="disease" ids="C0700323,C0234119" disease_type="Disease or Syndrome" abbrv="">neuromuscular blockades</z:e> with avoidance of serious side effects and very comfortable conditions for intubation in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="8" pm="."><plain>Minor side effects such as <z:hpo ids='HP_0001609'>hoarseness</z:hpo>, throat discomfort (in up to 30%) and <z:hpo ids='HP_0003326'>myalgia</z:hpo> (10%) for up to 48 h were documented </plain></SENT>
</text></document>